Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-02-22
2023-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Study Investigating the Effects of a Novel Weight Management Program
NCT01875354
Research Study of Nutritional Methods to Reduce Body Fat Percentages in Overweight and Obese Populations
NCT00487344
Choosing Healthy Activities and Lifestyle Management Through Portal Support
NCT05410353
Lifestyle, Exercise and Nutrition Study 1
NCT02109068
Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons
NCT00960414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Nutrition program
Subjects in this arm will follow the Active Nutrition program for 60 days with study visits at 0 days, 30 days, and 60 days.
meal replacements and supplements
Consumed daily: 2 Nutrimeal Active meal replacement shake, 1 electrolyte replacement drink, 3 metabolism + supplements, 1 whole food meal, and whole food snacks consisting of fruits and vegetables. 1200-1600 calories per day
Regular Diet
Subjects in this arm will follow their regular diet for 60 days with study visits at 0 days, 30 days, and 60 days.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
meal replacements and supplements
Consumed daily: 2 Nutrimeal Active meal replacement shake, 1 electrolyte replacement drink, 3 metabolism + supplements, 1 whole food meal, and whole food snacks consisting of fruits and vegetables. 1200-1600 calories per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* weigh less than 500 lbs
* able to fast overnight (greater than 10 hours)
Exclusion Criteria
* diagnosed with type 1 or 2 diabetes
* diagnosed with liver disease
* adversity to fiber or protein supplements
* allergic to any of the ingredients
* taking a weight loss dietary supplement or adhering to a weight loss plan for the month prior to or during the study
* consumption of alcohol within 24 hours of study visit
* consumption of caffeine within 24 hours of study visit
* strenuous exercise within 24 hours of study visit
* self-reported active infection or illness
* pregnant or lactating
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USANA Health Sciences
INDUSTRY
University of Memphis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michelle Stockton, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Memphis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Nutraceutical and Dietary Supplement Reseach
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-FY2022-181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.